Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

Gynecologic oncology - 1 Jan 2005

Metcalfe Kelly A, Lynch Henry T, Ghadirian Parviz, Tung Nadine, Olivotto Ivo A, Foulkes William D, Warner Ellen, Olopade Olufunmilayo, Eisen Andrea, Weber Barbara, McLennan Jane, Sun Ping, Narod Steven A

Abstract excerpt

OBJECTIVE: To estimate the risk of ovarian cancer after a primary diagnosis of breast cancer among women with a BRCA1 or BRCA2 mutation and to identify host and treatment-related factors that might modify the risk. PATIENTS AND METHODS: Patients were 491 women with stage I or stage II breast cancer, diagnosed from 1975 to 2000 and for whom a BRCA1 or BRCA2 mutation had been identified. Patients were followed from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Neoplasms, Second Primary

Share to Ovarian Neoplasms

Share to Tamoxifen

Source

Identifiers

PMID: 15589605
DOI: 10.1016/j.ygyno.2004.09.039

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.PMID 15589605Read ↗

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.Semantic proximity Read ↗

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.Semantic proximity Read ↗

Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.Semantic proximity Read ↗

Breast cancer following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.